The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility

• Magdalena H. Menhofer,

  Affiliation Department of Pharmacy, Pharmaceutical Biology, University of Munich, Munich, Germany

  ⨯
• Rebekka Kubisch,

  Affiliation Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich, Germany

  ⨯
• Laura Schreiner,

  Affiliation Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich, Germany

  ⨯
• Matthias Zorn,

  Affiliation Department of Physics, Soft Matter Physics and Biophysics, University of Munich, Munich, Germany

  ⨯
• Florian Foerster,

  Affiliation Department of Pharmacy, Pharmaceutical Biology, University of Munich, Munich, Germany

  ⨯
• Rolf Mueller,

  Affiliation Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany

  ⨯
• Joachim O. Raedler,

  Affiliation Department of Physics, Soft Matter Physics and Biophysics, University of Munich, Munich, Germany

  ⨯
• Ernst Wagner,

  Affiliation Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich, Germany

  ⨯
• Angelika M. Vollmar,

  Affiliation Department of Pharmacy, Pharmaceutical Biology, University of Munich, Munich, Germany

  ⨯
• Stefan Zahler

  * E-mail: stefan.zahler@cup.uni-muenchen.de

  Affiliation Department of Pharmacy, Pharmaceutical Biology, University of Munich, Munich, Germany

  ⨯